Cargando...
IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway
Although the Th17 subset and its signature cytokine, interleukin (IL)-17A (IL-17), are implicated in certain autoimmune diseases, their role in cancer remains to be further explored. IL-17 has been shown to be elevated in several types of cancer, but how it might contribute to tumor growth is still...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Idioma: | English |
| Publicado: |
The Rockefeller University Press
2009
|
| Materias: | |
| Acceso en liña: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715087/ https://www.ncbi.nlm.nih.gov/pubmed/19564351 http://dx.doi.org/10.1084/jem.20090207 |